Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting - Edgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, Carlos Vrech, María A Zarate

IJMS, Free Full-Text

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques - ScienceDirect

Frontiers Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

Cross-validation of function for the separation of neuromyelitis optica

Contrasting the brain imaging features of MOG-Antibody disease, with AQP4- Antibody NMOSD and Multiple Sclerosis

MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease - Carnero Contentti - 2023 - Journal of Neuroimaging - Wiley Online Library

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis

Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease - Carnero Contentti - 2023 - Journal of Neuroimaging - Wiley Online Library